Ignite Creation Date:
2024-05-06 @ 1:03 PM
Last Modification Date:
2024-10-26 @ 1:08 PM
Study NCT ID:
NCT03927456
Status:
UNKNOWN
Last Update Posted:
2021-06-03
First Post:
2019-04-17
Brief Title:
A Study of SHR6390 in Combination With Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
Sponsor:
Jiangsu HengRui Medicine Co Ltd
Organization:
Jiangsu HengRui Medicine Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-13
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-04-17
First Submit QC Date:
April 24 2019
Study First Post Date:
2019-04-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-31
Last Update Post Date:
2021-06-03
Last Update Post Date Type:
ACTUAL